Healthy volunteers to compare two vitamin B12 shots in small bioequivalence trial

NCT ID NCT07158099

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 23 times

Summary

This study checks whether a new version of methylconalamin (a type of vitamin B12) injection works the same as the standard version. Fourteen healthy adults will receive both injections at different times, with a washout period in between. The goal is to see if the two formulations are bioequivalent, meaning they produce similar levels in the blood. No treatment benefit is expected for participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THERAPEUTIC EQUIVALENCY, HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.